American Century Companies’s Cerevel Therapeutics Holdings, Inc. Common Stock CERE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q1
Sell
-413,203
Closed -$17.5M 2974
2023
Q4
$17.5M Buy
413,203
+105,460
+34% +$4.47M 0.01% 922
2023
Q3
$6.72M Sell
307,743
-1,504
-0.5% -$32.8K 0.01% 1225
2023
Q2
$9.83M Buy
309,247
+55,246
+22% +$1.76M 0.01% 1057
2023
Q1
$6.18M Buy
254,001
+2,677
+1% +$65.2K ﹤0.01% 1184
2022
Q4
$7.93M Buy
+251,324
New +$7.93M 0.01% 1056